METHOD OF TREATING PATIENTS WITH ALLERGIC RHINITIS WITH DISTURBED MICROBE LANDSCAPE OF NASAL MUCOSA Russian patent published in 2020 - IPC A61K31/787 A61K33/14 A61K36/484 A61K36/738 A61K33/30 A61K33/18 A61K35/66 A61P11/02 

FIELD: medicine.

SUBSTANCE: invention refers to medicine, namely to otorhinolaryngology, and can be used for treating patients with allergic rhinitis with disturbed microbial landscape of nasal mucosa. That is ensured by a three-stage conservative therapy: at the first stage, administering the poly-oxidonium immunomodulator in tablet form 12 mg twice a day orally for 10 days according to scheme 1, 2, 4, 6, 8, 11, 14, 17, 20, 23 days, in accordance with the patient's immune system changes; at the second stage, from the fifth day from reception of polyoxidonium, on the basis of bacteriological research taking into account sensitivity the antibacterial therapy and elimination therapy by a preparation of dolphin 2 times a day is carried out for 10 days; at the third stage, after the course of the antibacterial and elimination therapy, Maxillac synbiotic is administered orally 1 capsule per day for 20 days and polyvalent bacteriophage 5 drops in each half of nose 3 times/day for 14 days.

EFFECT: method has a stable therapeutic effect with more complete recovery of nasal breathing and olfaction, reduced or disappearing intensity of paroxysmal sneezing attacks, rhinorrhea, manifestations of conjunctivitis and chronic sinusitis.

1 cl, 7 tbl, 2 ex